I. Kalomenidis (Athens, Greece), D. Bumbacea (Bucharest, Romania)
Clinical, immunohistochemical and genetic analysis of 50 thymic epithelial tumours managed in Rennes University Hospital between 2000 and 2011
M. Kerjouan, S. Jouneau, N. Choukeir, D. C. Chiforeanu, A. Lespagnol, M. A. Belaud-Rotureau, H. Léna, R. Corre, B. Desrues (Rennes, France)
|   |
Thymoma: A retrospective analysis of 20 years in a cardiothoracic surgery department
C. Lares dos Santos, M. Sousa, F. Leite, J. Bernardo, L. Carvalho, M. Antunes (Coimbra, Portugal)
| |
beta1 and beta2 adrenergic receptors are significantly under-expressed in malignant pleural mesothelioma
D. Magouliotis, V. Tasiopoulou, I. Lempesis, R. Jagirdar, E. Solenov, C. Hatzoglou, P. A. Molyvdas, K. Gourgoulianis, S. Zarogiannis (Larissa, Greece; Novosibirsk, Russian Federation)
| |
Pleurodesis for malignant pleural effusions: A comparison of bleomycin or tranexamic acid alone versus a combination of both
E. Mohamed, E. Ali, H. Mahmoud (Sohag, Egypt)
| |
Efficacy of cytology, cell blocks and thoracoscopic pleural biopsy in malignant pleural effusion diagnosis
E. Altman, L. Spiridonov, S. Vadim, L. Alejandro, G. Alexei, C. I. Hector (Nahariya, Israel)
| |
Survival of mesothelioma patients after radical extrapleural pneumonectomy in the Nancy Biobank’s database
F. Vlastos, G. Kaltsakas, J. M. Vignaud, N. M. Martinet, N. G. Koulouris (Athens, Greece; Nancy, Nice, France)
| |
High fluorescence cells in pleural fluid. Association with pleural malignancy
D. Badenes, A. Supervía, F. Del Baño, S. Herrera, C. Vilaplana, T. Torrella, I. Cirera, O. Pallás (Barcelona, Spain)
| |
A computed tomography score to predict malignant pleural effusions
S. Bielsa, M. Pardina, A. González, J. M. Porcel (Lleida, Spain)
| |
Pleural eicosanoids in patients with lung cancer
J. H. Cho, S. Park, H. Nam, S. Kwak, J. Ryu, H. Lee (Incheon, Seoul, Republic Of Korea)
| |
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
M. Sivori, P. Ferro, P. Canessa, E. Battolla, P. Dessanti, M. C. Franceschini, L. Chiaffi, A. Morabito, V. Fontana, R. Pezzi, F. Fedeli, M. P. Pistillo, S. Roncella (Sarzana, La Spezia, Genova, Italy)
| |
Prognostic impact of histology and treatment modalities in malignant mesothelioma
T. Blum, J. Kollmeier, S. Griff, T. Weiss, W. Ammenwerth, S. Delis, W. Nehls, T. Sabha, S. Thiel, N. Schönfeld, T. T. Bauer (Berlin, Germany)
| |
1,25-dihydroxyvitamin D in malignant and non-malignant pleural effusions
M. Panagiotou, A. I. Papaioannou, F. Diamantea, S. Giannakaki, E. M. Antonogiannaki, S. Pouriki, A. Kalkanis, A. Takou, G. D. Maropoulos, E. Kastanakis, V. Polychronopoulos, K. Kostikas, N. Karagianidis (Athens, Greece)
| |
A novel pleural-bladder pump for management of pleural effusion
P. Astoul, Y. C. G. Lee, N. A. Maskell, C. H. Marquette, N. Johnson, S. Whittaker, E. Fonck (Marseille, Nice, France; Perth, Australia; Bristol, United Kingdom; Zurich, Switzerland)
| |
Exposure assessment and co-morbidity in females with malignant mesothelioma referred to an occupational clinic
O. Omland, T. Malling, J. P. Johansen, J. Hansen (Aalborg, Copenhagen, Denmark)
| |
Pleural ultrasound & the pulmonologist's toolkit
B. Khan (Dartford, United Kingdom)
| |
Ultrasound-guided cutting-needle biopsy for diagnosing pleural disease: Experience in Oxford
R. J. Hallifax, J. P. Corcoran, H. Rostom, N. M. Hassan, M. Nagendran, A. Manuel, N. M. Rahman (Oxford, United Kingdom)
| |
Change in LDH assay can affect classification of pleural effusions using Light's criteria
M. Evison, M. Al-Aloul, A. Bentley, N. Chaudhuri, E. Hinchliffe, A. M. Kelly, J. Holme (Manchester, United Kingdom)
| |